Distance-saturation product of the 6-minute walk test predicts mortality of patients with non-cystic fibrosis bronchiectasis

Journal of Thoracic Disease

Volumn 9, Issue 9, 2017, Pages 3168-3176

  Hsieh, Meng Heng ^a   Fang, Yueh Fu ^a   Chung, Fu Tsai ^a   Lee, Chung Shu ^a   Chang, Yu Chen ^a   Liu, Yuan Zhang ^a   Wu, Cheng Hsien ^a   Lin, Horng Chyuan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

6 minute walk test (6MWT); Distance saturation product (DSP); Mortality; Non cystic fibrosis (non CF) bronchiectasis

Indexed keywords

IMMUNOGLOBULIN E;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BRONCHIECTASIS; CAUSE OF DEATH; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISTANCE SATURATION PRODUCT; EXERCISE INDUCED OXYGEN DESATURATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; FUNCTIONAL STATUS; HEMATEMESIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NON CYSTIC FIBROSIS BRONCHIECTASIS; NONHUMAN; OXYGEN DESATURATION; OXYGEN SATURATION; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT PARAMETERS; SENSITIVITY AND SPECIFICITY; SIX MINUTE WALK TEST; SPIROMETRY; SURVIVAL RATE; SURVIVAL TIME; SURVIVOR;

EID: 85030088378     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.21037/jtd.2017.08.53     Document Type: Article

References (26)

1. Fuschillo S, De Felice A, Balzano G. Mucosal inflammation in idiopathic bronchiectasis:cellular and molecular mechanisms. Eur Respir J 2008;31:396-406.
2. ReiffDB, Wells AU, Carr DH, et al. CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. AJR Am J Roentgenol 1995;165:261-7.
3. Ooi GC, Khong PL, Chan-Yeung M, et al. Highresolution CT quantification of bronchiectasis: clinical and functional correlation. Radiology 2002;225:663-72.
4. Pasteur MC, Bilton D, Hill AT, et al. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010;65 Suppl 1:i1-58.
5. McShane PJ, Naureckas ET, Tino G., et al. Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med 2013;188:647-56.
6. Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med 2014;189:576-85.
7. Martínez-García Má, de Gracia J, Vendrell Relat M, et al. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J 2014;43:1357-67.
8. Kent BD, Mitchell PD, McNicholas WT. Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis 2011;6:199-208.
9. Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000;161:487-92.
10. Lama VN, Flaherty KR, Toews GB, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003;168:1084-90.
11. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
12. Lee AL, Button BM, Ellis S, et al. Clinical determinants of the 6-Minute Walk Test in bronchiectasis. Respir Med 2009;103:780-5.
13. Lettieri CJ, Nathan SD, Browning RF, et al. The distancesaturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med 2006;100:1734-41.
14. Onen ZP, Gulbay BE, Sen E, et al. Analysis of the factors related to mortality in patients with bronchiectasis. Respir Med 2007;101:1390-7.
15. Loebinger MR, Wells AU, Hansell DM, et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J 2009;34:843-9.
16. Goeminne PC, Nawrot TS, Ruttens D, et al. Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis. Respir Med 2014;108:287-96.
17. Tsang KW, Tipoe GL. Bronchiectasis: not an orphan disease in the East. Int J Tuberc Lung Dis 2004;8:691-702.
18. Hallstrand TS, Boitano LJ, Johnson WC, et al. The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J 2005;25:96-103.
19. Eaton T, Young P, Milne D, et al. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005;171:1150-7.
20. Alhamad EH, Shaik SA, Idrees MM, et al. Outcome measures of the 6 minute walk test: relationships with physiologic and computed tomography findings in patients with sarcoidosis. BMC Pulm Med 2010;10:42.
21. Casanova C, Cote C, Marin JM, et al. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest 2008;134:746-52.
22. Ball MK, Waypa GB, Mungai PT, et al. Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1a. Am J Respir Crit Care Med 2014;189:314-24.
23. Dupont M, Gacouin A, Lena H, et al. Survival of patients with bronchiectasis after the first ICU stay for respiratory failure. Chest 2004;125:1815-20.
24. Takigawa N, Tada A, Soda R, et al. Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients. Respir Med 2007;101:561-7.
25. Mak VH, Bugler JR, Roberts CM, et al. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation. Thorax 1993;48:33-8.
26. Bourbonnais JM, Malaisamy S, Dalal BD, et al. Distance saturation product predicts health-related quality of life among sarcoidosis patients. Health Qual Life Outcomes 2012;10:67.